DNA X, Inc. (formerly Sonim Technologies, Inc.) filed Amendment No. 1 to its Current Report on Form 8-K, originally filed on December 18, 2025. The original report detailed the Company's purchase of 100% of membership interests in DNA X LLC from DNA Holdings Venture, Inc. on December 15, 2025. The purchase price for DNA X LLC was 223,201 shares of the Company's common stock, representing 19.99% of outstanding shares at issuance. This amendment revises Item 2.01 and Item 9.01, stating that the Company has determined the Transaction does not involve the acquisition of a significant amount of assets for Form 8-K purposes. Consequently, the Company is not required to disclose financial statements or pro forma financial information related to the Transaction, as previously set forth in the Original Report.